These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26966361)

  • 41. Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo.
    Robinson M; Oakes TM; Raskin J; Liu P; Shoemaker S; Nelson JC
    Am J Geriatr Psychiatry; 2014 Jan; 22(1):34-45. PubMed ID: 24314888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
    Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
    Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J
    Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between Painful Physical Symptoms and Clinical Outcomes in Korean Patients with Major Depressive Disorder: A Three-Month Observational Study.
    Lee MS; Yum SY; Hong JP; Yoon SC; Noh JS; Lee KH; Kim JK; Lee SY; Singh P; Treuer T; Reed V; Raskin J
    Psychiatry Investig; 2009 Dec; 6(4):255-63. PubMed ID: 20140123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
    Pollack MH; Endicott J; Liebowitz M; Russell J; Detke M; Spann M; Ball S; Swindle R
    J Psychiatr Res; 2008 Oct; 42(12):1042-9. PubMed ID: 18221755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?
    Hong J; Novick D; Montgomery W; Aguado J; Dueñas H; Peng X; Haro JM
    Clin Pract Epidemiol Ment Health; 2015; 11():130-9. PubMed ID: 25870649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
    BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
    Wohlreich MM; Martinez JM; Mallinckrodt CH; Prakash A; Watkin JG; Fava M
    J Clin Psychopharmacol; 2005 Dec; 25(6):552-60. PubMed ID: 16282837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder.
    Perahia DG; Kajdasz DK; Desaiah D; Haddad PM
    J Affect Disord; 2005 Dec; 89(1-3):207-12. PubMed ID: 16266753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of painful physical symptoms on depression outcomes in elderly Asian patients.
    Novick D; Montgomery W; Bertsch J; Peng X; Brugnoli R; Haro JM
    Int Psychogeriatr; 2014 Nov; ():1-8. PubMed ID: 25366979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study.
    Novick D; Montgomery W; Vorstenbosch E; Moneta MV; Dueñas H; Haro JM
    Patient Prefer Adherence; 2017; 11():1859-1868. PubMed ID: 29184393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors.
    Briley M; Moret C
    Neuropsychiatr Dis Treat; 2010 Oct; 6():647-55. PubMed ID: 20957125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial.
    Rajagopalan K; Bacci ED; Wyrwich KW; Pikalov A; Loebel A
    Int J Bipolar Disord; 2016 Dec; 4(1):7. PubMed ID: 26928122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the effectiveness of duloxetine in depressed patients with and without a family history of affective disorders in first-degree relatives.
    Wang S; Qian M; Zhong H; Song G; Lu M; Feng R; Zhang L; Ni J; Chen W
    Shanghai Arch Psychiatry; 2015 Aug; 27(4):237-45. PubMed ID: 26549960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duloxetine Exposure During Pregnancy and the Risk of Spontaneous and Elective Abortion: A Danish Nationwide Observational Study.
    Ankarfeldt MZ; Petersen J; Andersen JT; Fernandes MFS; Li H; Motsko SP; Fast T; Jimenez-Solem E
    Drugs Real World Outcomes; 2021 Sep; 8(3):289-299. PubMed ID: 34008161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parkinsonism secondary to duloxetine use: a case report.
    Bayrak A; Cetin B; Meteris H; Kesebir S
    North Clin Istanb; 2015; 2(3):243-246. PubMed ID: 28058376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid-onset hyponatremia induced by duloxetine in a middle-aged male with depression and somatic symptoms.
    Choi JS; Lee HW; Lee JY; Jung HY
    Psychiatry Investig; 2012 Mar; 9(1):83-4. PubMed ID: 22396690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Duloxetine-induced liver injury in patients with major depressive disorder.
    Kang SG; Park YM; Lee HJ; Yoon B
    Psychiatry Investig; 2011 Sep; 8(3):269-71. PubMed ID: 21994516
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.